Published in Stem Cell Reports on April 19, 2017
Harnessing OLIG2 Function in Tumorigenicity and Plasticity to Target Malignant Gliomas. Cell Cycle (2017) 0.75
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell (2010) 39.09
Identification of human brain tumour initiating cells. Nature (2004) 38.87
The somatic genomic landscape of glioblastoma. Cell (2013) 11.73
CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res (2007) 6.21
Neural stem cells and the origin of gliomas. N Engl J Med (2005) 5.43
Corridors of migrating neurons in the human brain and their decline during infancy. Nature (2011) 4.12
Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells. Cell (2014) 4.04
TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma. Cancer Cell (2010) 3.69
Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature (2015) 3.64
Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res (2008) 2.97
Malignant glioma: lessons from genomics, mouse models, and stem cells. Cell (2012) 2.85
Simultaneous prospective purification of adult subventricular zone neural stem cells and their progeny. Proc Natl Acad Sci U S A (2009) 2.72
Prospective identification and purification of quiescent adult neural stem cells from their in vivo niche. Neuron (2014) 2.25
Cancer stem cells in glioblastoma. Genes Dev (2015) 1.91
Localization of epidermal growth factor receptors and putative neuroblasts in human subependymal zone. J Comp Neurol (2000) 1.40
The interface between glial progenitors and gliomas. Acta Neuropathol (2008) 1.33
Prospective isolation of late development multipotent precursors whose migration is promoted by EGFR. Dev Biol (2005) 1.10
EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network Remodeling. Mol Cell (2015) 0.91
An epigenetic gateway to brain tumor cell identity. Nat Neurosci (2015) 0.85
Advances in genetic and epigenetic analyses of gliomas: a neuropathological perspective. J Neurooncol (2014) 0.79
EGFR promoter exhibits dynamic histone modifications and binding of ASH2L and P300 in human germinal matrix and gliomas. Epigenetics (2015) 0.78
Interactive Big Data Resource to Elucidate Human Immune Pathways and Diseases. Immunity (2015) 0.81